Global Anti-Nuclear Antibody (ANA) Testing Market will reach USD 1300.6 MN by 2023, registering a CAGR of approximately ~9.6% during the assessment period (2017 – 2023).
Market Overview:
The antinuclear antibody (ANA) test is a primary test used for determining autoimmune disorders that affect tissues and organs throughout the body (systemic). ANA test is also extensively used as one of the tests to help diagnose systemic lupus erythematosus (SLE) although a positive ANA test by itself does not diagnose any one particular disease. Also, the ANA test is helpful in determining autoimmune diseases such as rheumatoid arthritis and lupus.
The antinuclear antibody market is growing pervasively mainly due to the increased rate of prevalence of cancer over the past few years.
Free Sample https://www.marketresearchfuture.com/sample_request/3210
Major Players:
Key players leading the global anti-nuclear antibody testing market include Alere (US), Abcam plc. (US), Antibodies Inc. (US), Erba Diagnostics (US), Bio-Rad Laboratories, Inc. (US), Indur Services, Inc. (US), Merck KGaA (Germany), MBL International (US), and Trinity Biotech (Republic of Ireland) among others.
Conversely, high costs of the tests and poor reimbursement policies are impeding the growth of the market, especially in the developing regions. Besides, the unmet clinical needs alongside the unavailability of external funding are obstructing the market growth in the underdeveloped regions.
Global ANA Testing Market – Segments
For ease of understanding, the MRFR analysis has been segmented into four key dynamics: –
By Type : Immunofluorescence, Enzymelinked, and Immunosorbent Assay (ELISA) among others.
By Application : Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Polymyositis, Scleroderma, and Sjögren’s Syndrome among others.
By End-user : Hospitals & Clinics, Research Laboratories, and others.
By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World (RoW).
Additional factors allowing the market to boost further include substantial investments transpired into R&D to develop more advanced product and the improvements in the test that have occurred over the past couple of years. Moreover, factors such as the ever-increasing population that is increasingly inclining towards the sedentary lifestyle and urbanization support market growth. Improving economic conditions substantiate market growth, availing access to excellent healthcare by increasing healthcare expenditures.
Brows Detailed Research Report with TOC at https://www.marketresearchfuture.com/reports/anti-nuclear-antibody-testing-market-3210
Industry, Innovation & Related News
March 25, 2019 —– SourcingLink.net, Inc. (the US), a publicly traded exploration and development company announced a partnership with NanoSmart Pharmaceuticals, Inc. (the US), a biotech company developing a series of new drugs to treat cancer. Alongside the right to use NanoSmart’s nanoparticle platform technologies to develop and commercialize improved formulations of anti-nuclear antibody (ANA)-targeted doxorubicin for the treatment of human cancers the exclusive worldwide licensing agreement will also allow a significant extension to SourcingLink’s oncology product portfolio that can address the growing need for improved cancer therapies.
SourcingLink is further looking forward to initiating nonclinical development, clinical trials, FDA submission, and commercialization of a tumor-targeting drug product and to explore combination with its proprietary liquid biopsy platform to potentially deliver personalized treatment paradigms that are safer and more effective than existing options.
Global Anti-nuclear Antibody Testing Market – Competitive Analysis
Fiercely competitive, the anti-nuclear antibody testing appears to be fragmented due to many large and small players churning the competition in the market. These players try to gain an edge over their competitors by incorporating strategic initiatives such as acquisition, expansion, product/ technology launch, and collaboration.
Get an Amazing Discount at https://www.marketresearchfuture.com/check-discount/3210
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/anti-nuclear-antibody-testing-market-3210